Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary analysis reportPriya S. Kishnani, Yin‐Hsiu Chien, Anaïs Brassier et al.|Genetics in Medicine|2022Cited by 53